Alex Goldberg

NASDAQ Active Stock Watch List: Novavax, Inc. (NASDAQ:NVAX) and Cisco Systems, Inc. (NASDAQ:CSCO) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/17/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Novavax, Inc. (NASDAQ:NVAX) and Cisco Systems, Inc. (NASDAQ:CSCO).

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company that focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases closed down in its previous session (-1.38%) on 1,802,423 shares traded. Novavax, Inc. (NASDAQ:NVAX) is currently down (-13.69%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Novavax, Inc. (NASDAQ:NVAX)

Cisco Systems, Inc. (NASDAQ:CSCO) a company that designs, manufactures, and sells Internet protocol and other products related to the communications and information technology industry worldwide closed up in its previous session (+1.30%) on 64,577,320 shares traded after Cisco Reported Second Quarter Earnings. Cisco Systems, Inc. (NASDAQ:CSCO) is currently up (+13.96%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Cisco Systems, Inc. (NASDAQ:CSCO)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com